Skip to main content
. 2023 Jun 1;45(5):2785–2803. doi: 10.1007/s11357-023-00830-5

Fig. 2.

Fig. 2

Senolytic therapy reduces senescent cell burden. Subcutaneous adipose tissue (A) p16 and (B) p21 gene expression was significantly decreased after 3 months of intermittent dasatinib (D) and quercetin (Q) administration ([n = 9]; * = p < 0.05) compared to the tissue of those receiving vehicle (VEH; n = 7). All values presented are adjusted means ± SEM